465 related articles for article (PubMed ID: 16198274)
1. Progression in chronic kidney disease.
Eddy AA
Adv Chronic Kidney Dis; 2005 Oct; 12(4):353-65. PubMed ID: 16198274
[TBL] [Abstract][Full Text] [Related]
2. Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition.
Guarino M; Tosoni A; Nebuloni M
Hum Pathol; 2009 Oct; 40(10):1365-76. PubMed ID: 19695676
[TBL] [Abstract][Full Text] [Related]
3. Obstructive nephropathy: towards biomarker discovery and gene therapy.
Chevalier RL
Nat Clin Pract Nephrol; 2006 Mar; 2(3):157-68. PubMed ID: 16932414
[TBL] [Abstract][Full Text] [Related]
4. Prevention of progressive fibrosis in chronic renal diseases: antifibrotic agents.
Negri AL
J Nephrol; 2004; 17(4):496-503. PubMed ID: 15372410
[TBL] [Abstract][Full Text] [Related]
5. The role of tubular epithelial-mesenchymal transition in progressive kidney disease.
Burns WC; Kantharidis P; Thomas MC
Cells Tissues Organs; 2007; 185(1-3):222-31. PubMed ID: 17587828
[TBL] [Abstract][Full Text] [Related]
6. The renal cortical fibroblast in renal tubulointerstitial fibrosis.
Qi W; Chen X; Poronnik P; Pollock CA
Int J Biochem Cell Biol; 2006 Jan; 38(1):1-5. PubMed ID: 16230044
[TBL] [Abstract][Full Text] [Related]
7. Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects.
López-Hernández FJ; López-Novoa JM
Cell Tissue Res; 2012 Jan; 347(1):141-54. PubMed ID: 22105921
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies.
Yang T; Vesey DA; Johnson DW; Wei MQ; Gobe GC
Transl Res; 2007 Jul; 150(1):40-50. PubMed ID: 17585862
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow-derived myofibroblasts contribute to the renal interstitial myofibroblast population and produce procollagen I after ischemia/reperfusion in rats.
Broekema M; Harmsen MC; van Luyn MJ; Koerts JA; Petersen AH; van Kooten TG; van Goor H; Navis G; Popa ER
J Am Soc Nephrol; 2007 Jan; 18(1):165-75. PubMed ID: 17135399
[TBL] [Abstract][Full Text] [Related]
10. A pathogenic role for c-Jun amino-terminal kinase signaling in renal fibrosis and tubular cell apoptosis.
Ma FY; Flanc RS; Tesch GH; Han Y; Atkins RC; Bennett BL; Friedman GC; Fan JH; Nikolic-Paterson DJ
J Am Soc Nephrol; 2007 Feb; 18(2):472-84. PubMed ID: 17202416
[TBL] [Abstract][Full Text] [Related]
11. Myostatin promotes a fibrotic phenotypic switch in multipotent C3H 10T1/2 cells without affecting their differentiation into myofibroblasts.
Artaza JN; Singh R; Ferrini MG; Braga M; Tsao J; Gonzalez-Cadavid NF
J Endocrinol; 2008 Feb; 196(2):235-49. PubMed ID: 18252947
[TBL] [Abstract][Full Text] [Related]
12. Role of fibroblast activation in inducing interstitial fibrosis.
Zeisberg M; Strutz F; Müller GA
J Nephrol; 2000; 13 Suppl 3():S111-20. PubMed ID: 11132027
[TBL] [Abstract][Full Text] [Related]
13. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
Wagrowska-Danilewicz M; Stasikowska O; Danilewicz M
Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
[TBL] [Abstract][Full Text] [Related]
14. The contribution of bone marrow-derived cells to the development of renal interstitial fibrosis.
Li J; Deane JA; Campanale NV; Bertram JF; Ricardo SD
Stem Cells; 2007 Mar; 25(3):697-706. PubMed ID: 17170067
[TBL] [Abstract][Full Text] [Related]
15. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts.
Danilewicz M; Wagrowska-Danilewicz M
Pathol Res Pract; 2006; 202(1):9-15. PubMed ID: 16343799
[TBL] [Abstract][Full Text] [Related]
16. The role of lymphocytes in the progression of interstitial disease.
Strutz F; Neilson EG
Kidney Int Suppl; 1994 Feb; 45():S106-10. PubMed ID: 8158876
[TBL] [Abstract][Full Text] [Related]
17. [The management in chronic kidney disease (CKD)].
Busuioc M; Gusbeth-Tatomir P; Covic A
Rev Med Chir Soc Med Nat Iasi; 2008; 112(4):896-901. PubMed ID: 20209759
[TBL] [Abstract][Full Text] [Related]
18. [Inflammatory mechanisms of renal fibrosis: glomerulonephritis].
Baud L; Fouqueray B; Bellocq A
Bull Acad Natl Med; 1999; 183(1):23-31. PubMed ID: 10371762
[TBL] [Abstract][Full Text] [Related]
19. Safflower extract: a novel renal fibrosis antagonist that functions by suppressing autocrine TGF-beta.
Yang YL; Chang SY; Teng HC; Liu YS; Lee TC; Chuang LY; Guh JY; Chang FR; Liao TN; Huang JS; Yeh JH; Chang WT; Hung MY; Wang CJ; Chiang TA; Hung CY; Hung TJ
J Cell Biochem; 2008 Jun; 104(3):908-19. PubMed ID: 18189272
[TBL] [Abstract][Full Text] [Related]
20. Relationship of transforming growth factor-beta(1) with tumour necrosis factor-alpha and endothelial activation in patients with stable renal transplantation.
Palermo A; Mulè G; Vadalà A; Vaccaro F; Guarneri M; Arsena R; Briolotta C; Cerasola G; Cottone S
Nephrology (Carlton); 2008 Apr; 13(2):164-70. PubMed ID: 18275506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
